ORTH Insider Trading (Ortho Regenerative Technologies)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $26,962.00
Insider Selling (Last 12 Months): $0.00
Ortho Regenerative Technologies Share Price & Price History
Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 07/3/2020 01:00 AM ET
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Ortho Regenerative Technologies Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/23/2021||Guy Paul Allard||Senior Officer||Buy||8,775||$0.48||$4,212.00||122,250|
|8/20/2021||Luc Mainville||Senior Officer||Buy||50,000||$0.46||$22,750.00||956,000|
|10/29/2020||Manitex Capital Inc. ||Insider||Sell||160,000||$0.56||$89,600.00||5,018,858|
|10/19/2020||Luc Mainville||Senior Officer||Buy||1,000||$0.60||$600.00||906,000|
|4/21/2020||Luc Mainville||Senior Officer||Buy||244,000||$0.50||$122,000.00||708,000|
|9/27/2019||Guy Paul Allard||Senior Officer||Buy||1,250||$0.29||$362.50||27,350|
|9/24/2019||Guy Paul Allard||Senior Officer||Buy||1,500||$0.26||$390.00||26,100|
|9/16/2019||Guy Paul Allard||Senior Officer||Buy||1,000||$0.29||$290.00||24,600|
|9/13/2019||Guy Paul Allard||Senior Officer||Buy||3,000||$0.31||$930.00||23,600|
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
SEC Filings (Institutional Ownership Changes) for Ortho Regenerative Technologies (CNSX:ORTH)
Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of Ortho Regenerative Technologies?